发明名称 |
Mutant human T-cell line esp. ATCC CRL 8295 |
摘要 |
<p>(1) Stable 6-thioguanine (I)-resistant mutant of the lymphoblastoid cell line CEM and secreting constitutively a high titre of a non-mitogenic non-cytotoxic T-cell suppressor inducer factor. The mutant cell line is esp. ATCC CRL 8295 or 8296. (2) Suppressor inducer factor having the following properties: (a) a dilution to 10 to minus 6, it suppresses at least 90% of mitogen-induced T-cell proliferation; (b) it is contained in a protein of molecular wt. about 110000 daltons; (c) it shows max. suppressor activity at physiological pH; (d) it is inactivated at 56 deg.C; (e) it is non-mitogenic and non-cytotoxic; (f) it suppresses mouse spleen cell proliferation to mitogenic stimulation with the same potency as it suppresses human peripheral blood lymphocyte proliferation to mitogenic stimulation. (3) Non-mitogenic non-cytotoxic T-cell suppressor factor suppressing at least 90% of T-cell proliferation to mitogenic stimulation at a dilution of 2 times 10 to minus 4. Its suppressive activity is blocked by rhamnose.</p> |
申请公布号 |
ES8603569(A1) |
申请公布日期 |
1986.04.16 |
申请号 |
ES19930005325 |
申请日期 |
1984.05.17 |
申请人 |
ORTHO PHARMACEUTICAL (CANADA) LTD. |
发明人 |
|
分类号 |
G01N33/577;A61K35/12;A61K35/28;A61K38/00;A61K38/11;A61K38/16;A61P37/06;C07K14/00;C07K14/52;C12N5/0789;C12N5/10;C12N15/02;C12P21/00;C12P21/08;C12R1/91;G01N33/564;(IPC1-7):C12N15/00;C12N5/00 |
主分类号 |
G01N33/577 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|